Surveillance and the Future of Standing, and More from CRS
It may be easier for litigants to mount a constitutional challenge to intelligence surveillance programs that gather U.S. data such as telephone and internet metadata now that those programs have been documented through leaks of classified records. Or, says a new report from the Congressional Research Service, it may not be.
Unlike previous cases, “the litigants in these newly filed lawsuits would appear to have a stronger argument for how they have been injured [than prior litigants did, and they] have evidence that the government is actually using its authority to gather data that is pertinent to the plaintiffs,” the CRS report said.
“However, the plaintiffs in these lawsuits may still have significant difficulties in establishing standing, as they have arguably not alleged that they have been specifically targeted by the government or injured in any concrete and particularized way by the government’s conduct,” the CRS author speculates. See Foreign Surveillance and the Future of Standing to Sue Post-Clapper, July 10, 2013.
Other new or newly updated CRS reports include the following.
Cluster Munitions: Background and Issues for Congress, July 9, 2013
Points of Order in the Congressional Budget Process, July 11, 2013
Europe’s Energy Security: Options and Challenges to Natural Gas Supply Diversification, July 11, 2013
Kuwait: Security, Reform, and U.S. Policy, July 10, 2013
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.